About
ArriVent BioPharma, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, including targeted therapies and antibody drug conjugates for difficult-to-treat cancers.
Explore ArriVent BioPharma, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.